Search Results for 'Drug-eluting stent'

A major research project between CÚRAM, the SFI Research Centre for Medical Devices based at National University Ireland (NUI) Galway, and Boston Scientific, that will enhance medical devices that allow surgeons to support minimally invasive procedures when carrying out life-saving repairs for aneurysms and aortic valve repair, was announced by Taoiseach Leo Varadkar in Washington last evening.

The Promus PREMIER™ Stent System, a new generation coronary stent manufactured by Boston Scientific in Ballybrit, Galway, was successfully implanted for the first time worldwide at the Trinity Centre for Health Sciences at the 10th Annual Live PCI Course held at St. James Hospital this month. This is the seventh drug-eluting coronary stent developed and commercialised by Boston Scientific over the past 10 years.

The Promus PREMIER™ Stent System, a new generation coronary stent manufactured by Boston Scientific in Ballybrit, Galway, was successfully implanted for the first time worldwide at the Trinity Centre for Health Sciences at the 10th Annual Live PCI Course held at St. James Hospital this month. This is the seventh drug-eluting coronary stent developed and commercialised by Boston Scientific over the past 10 years.

The Cardiology Department in University Hospital Galway has become the first department in Ireland to use ground-breaking cardiology technology, which will significantly improve the detection of cholesterol build narrowings within the coronary artery.

Boston Scientific announced this week that is has bought Galway biotech company Labcoat Ltd for an undisclosed sum.

A MEDICAL devices group based in Ballybrit has raised $17.3 million (€12.4 million) in funding to launch the company’s first product — a coronary stent designed to prevent blockages of smaller arteries feeding the heart.